Left Menu
Development News Edition

EU watchdog paves way for dexamethasone use in COVID-19 treatment

Europe's health regulator has endorsed using dexamethasone to treat severely ill COVID-19 patients with breathing difficulty, paving way for the steroidal medication to possibly become the region's second approved medication for the illness. The European Medicines Agency (EMA) on Friday concluded in its review of results from a trial by British scientists that the drug could be an option to treat adults and adolescents needing oxygen therapy or mechanical ventilation.

Reuters | Updated: 18-09-2020 17:22 IST | Created: 18-09-2020 16:49 IST
EU watchdog paves way for dexamethasone use in COVID-19 treatment
Representative Image Image Credit: Pixabay

Europe's health regulator has endorsed using dexamethasone to treat severely ill COVID-19 patients with breathing difficulty, paving way for the steroidal medication to possibly become the region's second approved medication for the illness.

The European Medicines Agency (EMA) on Friday concluded in its review of results from a trial by British scientists that the drug could be an option to treat adults and adolescents needing oxygen therapy or mechanical ventilation. Gilead's antiviral drug, remdesivir, was the first to be approved for COVID-19 by Europe in July, a month after the EMA endorsed the drug.

While approvals are up to the European Commission, it typically follows the EMA's recommendation for its decision. Companies that sell the widely available and low-cost dexamethasone, commonly used against a range of inflammatory conditions, can now apply for a license on the expanded use to their national regulators or the EMA, the watchdog said.

It said the recommended dose of the treatment in adults and adolescents, from the age of 12 years and weighing at least 40 kilograms, is 6 milligrams once a day for up to 10 days.


TRENDING

OPINION / BLOG / INTERVIEW

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Guinea’s elections hearken back to the autocracy and violence of its past

... ...

Videos

Latest News

Trump the dancer? His moves to 'YMCA' at rallies are a hit

He adjusts his coat. He gazes out at the crowd. And then he goes for it. President Donald Trump, a man who is famously particular about his appearance, is fully embracing doing a dad dance to the Village Peoples YMCA as the finale to his ra...

Spammers and scammers using U.S. election to turn profit online, Facebook says

Fraudsters from Albania to Vietnam are posting about U.S. politics and the upcoming presidential election to build fake audiences, maximise clicks and make money online, Facebook Inc said on Wednesday. In a new report about so-called inauth...

Golf-Scott withdraws from Zozo after testing positive for COVID-19

Australian Adam Scott has withdrawn from the Zozo Championship after testing positive for COVID-19, the PGA Tour said onWednesday. Scott, the winner of 14 PGA Tour titles, last competed in Septembers U.S. Open and was expected to be among t...

'Terrible situation': Spain first European nation to top 1 million COVID-19 cases

Spain became the first Western European country to exceed 1 million COVID-19 infections on Wednesday, doubling its tally in just six weeks despite a series of increasingly stringent measures to control the second wave of the virus. Health m...

Give Feedback